Contraception Clinical Trial
Official title:
Patient-Centered Support for Contraceptive Decision-Making: A Cluster Randomized Controlled Trial of a Contraceptive Decision Support Tool
The investigators have designed a tablet-based decision support tool to help women learn more
about their birth control options and support them in choosing a method they are happy with.
The investigators will test whether the decision support tool helps women choose a birth
control method they can continue using successfully by having some women use the tool before
their birth control-related visit to a health care provider, and some women not use the tool
before their visit. The investigators will then follow up with all the women at four months
and seven months after their visit to see if they are still using the birth control method
they chose at the visit and how happy they are with the method.
Hypotheses:
1. Women who use the contraceptive decision support tool will be more likely to continue
using their chosen method at 4 and 7 months follow-up, compared to women who receive
usual care.
2. The contraceptive decision support tool will increase women's knowledge, choice of, and
use of highly effective reversible contraception, compared to usual care.
3. The contraceptive decision support tool will decrease decision conflict, compared to
usual care.
4. The contraceptive decision support tool will increase patient satisfaction with the
clinic visit and with their method, compared to usual care.
5. Women who use the contraceptive decision support tool will have fewer unintended
pregnancies during the follow-up period, compared to women who received usual care.
6. The contraceptive decision support tool will increase shared patient-provider decision
making in contraceptive counseling visits, compared to usual care.
7. The contraceptive decision support tool will decrease provider frustration when
providing contraceptive counseling and increase provider job satisfaction.
8. Women using the tool will be more likely to report use of any moderately or highly
effective method of contraception at 4 and 7 months follow-up, compared to women not
using the tool.
The impacts of unintended pregnancy include adverse maternal and infant outcomes for women
who continue their pregnancies, with higher rates of infant low birth weight, infant
mortality, and maternal mortality and morbidity for these pregnancies as compared to planned
pregnancies. In addition, children resulting from unplanned pregnancies have been found to be
more likely to experience developmental delay.
Over the past several decades, the proportion of unintended pregnancy in the United States
has remained stubbornly high at approximately 50%. Each year, one in 20 women of reproductive
age experiences an unintended pregnancy, and it is estimated that over half of women will
have an unintended pregnancy in their lifetime. This high rate of unintended pregnancy in the
United States places a heavy burden on both women and the health care system. A
disproportionate amount of this burden is experienced by minority women and women of lower
socioeconomic status. Given the high rate of unintended pregnancies in this country,
interventions designed to help women achieve their fertility goals could have a substantial
impact on their health outcomes and life course. In addition, identifying strategies that are
appropriate for use in high-risk, diverse populations could address disparities in women's
ability to plan their pregnancies.
The investigators propose a cluster randomized trial to investigate the effect of an
interactive, tablet-based contraceptive decision support tool that women will use immediately
prior to their contraceptive counseling visits. The goal of the tool is to facilitate shared
decision-making between the woman and her health care provider, with the ultimate goal of
helping the woman to choose a contraceptive method that is consistent with her values and
preferences, and is therefore best suited to helping her to avoid an unplanned pregnancy. The
tool will be available in both English and Spanish.
The investigators will measure the tool's effect on women's contraceptive continuation, as
well as on their experience of contraceptive counseling, measured both quantitatively and
qualitatively. In addition, the investigators will collect quantitative and qualitative data
to determine the impact of the implementation of this tool on the experiences of providers
and the clinics in which they work.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |